HEADER VIRAL PROTEIN 20-JUL-23 8K4P TITLE CRYO-EM STRUCTURE OF AN ACTIVE KAPOSI'S SARCOMA-ASSOCIATED TITLE 2 HERPESVIRUS-G PROTEIN-COUPLED RECEPTOR (KSHV-GPCR) IN COMPLEX WITH GI TITLE 3 PROTEIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: GUANINE NUCLEOTIDE-BINDING PROTEIN G(I)/G(S)/G(T) SUBUNIT COMPND 3 BETA-1; COMPND 4 CHAIN: B; COMPND 5 SYNONYM: TRANSDUCIN BETA CHAIN 1; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: G PROTEIN-COUPLED RECEPTOR; COMPND 9 CHAIN: A; COMPND 10 ENGINEERED: YES; COMPND 11 MOL_ID: 3; COMPND 12 MOLECULE: GUANINE NUCLEOTIDE-BINDING PROTEIN G(I) SUBUNIT ALPHA-1; COMPND 13 CHAIN: C; COMPND 14 SYNONYM: ADENYLATE CYCLASE-INHIBITING G ALPHA PROTEIN; COMPND 15 ENGINEERED: YES; COMPND 16 MOL_ID: 4; COMPND 17 MOLECULE: GUANINE NUCLEOTIDE-BINDING PROTEIN SUBUNIT GAMMA; COMPND 18 CHAIN: G; COMPND 19 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: GNB1; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: HUMAN GAMMAHERPESVIRUS 8; SOURCE 10 ORGANISM_TAXID: 37296; SOURCE 11 GENE: ORF74; SOURCE 12 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 13 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 14 MOL_ID: 3; SOURCE 15 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 16 ORGANISM_COMMON: HUMAN; SOURCE 17 ORGANISM_TAXID: 9606; SOURCE 18 GENE: GNAI1; SOURCE 19 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 20 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 21 MOL_ID: 4; SOURCE 22 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 23 ORGANISM_COMMON: HUMAN; SOURCE 24 ORGANISM_TAXID: 9606; SOURCE 25 GENE: GNG2; SOURCE 26 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 27 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS KAPOSI'S SARCOMA-ASSOCIATED HERPESVIRUS-G PROTEIN-COUPLED RECEPTOR, KEYWDS 2 KSHV-GPCR, HHV8, VIRAL PROTEIN EXPDTA ELECTRON MICROSCOPY AUTHOR Y.Z.LIU,A.J.LIU REVDAT 1 24-JUL-24 8K4P 0 JRNL AUTH Y.Z.LIU,A.J.LIU JRNL TITL CRYO-EM STRUCTURE OF ACTIVE KAPOSI'S SARCOMA-ASSOCIATED JRNL TITL 2 HERPESVIRUS-G PROTEIN-COUPLED RECEPTOR (KSHV-GPCR) IN JRNL TITL 3 COMPLEX WITH GI PROTEIN JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.81 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : NULL REMARK 3 RECONSTRUCTION SCHEMA : NULL REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : NULL REMARK 3 REFINEMENT SPACE : NULL REMARK 3 REFINEMENT PROTOCOL : NULL REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 2.810 REMARK 3 NUMBER OF PARTICLES : 179737 REMARK 3 CTF CORRECTION METHOD : PHASE FLIPPING AND AMPLITUDE REMARK 3 CORRECTION REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 8K4P COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 21-JUL-23. REMARK 100 THE DEPOSITION ID IS D_1300039523. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : PARTICLE REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : AN ACTIVE KAPOSI'S SARCOMA REMARK 245 -ASSOCIATED HERPESVIRUS-G REMARK 245 PROTEIN-COUPLED RECEPTOR (KSHV- REMARK 245 GPCR) IN COMPLEX WITH GI PROTEIN REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : NULL REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : NULL REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 7.40 REMARK 245 SAMPLE DETAILS : NULL REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : NULL REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : FEI TITAN KRIOS REMARK 245 DETECTOR TYPE : GATAN K3 BIOQUANTUM (6K X REMARK 245 4K) REMARK 245 MINIMUM DEFOCUS (NM) : 1200.00 REMARK 245 MAXIMUM DEFOCUS (NM) : 2500.00 REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : NULL REMARK 245 IMAGING MODE : BRIGHT FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 5000.00 REMARK 245 ILLUMINATION MODE : FLOOD BEAM REMARK 245 NOMINAL MAGNIFICATION : NULL REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 300 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, A, C, G REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET C 1 REMARK 465 ALA C 59 REMARK 465 GLY C 60 REMARK 465 TYR C 61 REMARK 465 SER C 62 REMARK 465 GLU C 63 REMARK 465 GLU C 64 REMARK 465 GLU C 65 REMARK 465 CYS C 66 REMARK 465 LYS C 67 REMARK 465 GLN C 68 REMARK 465 TYR C 69 REMARK 465 LYS C 70 REMARK 465 ALA C 71 REMARK 465 VAL C 72 REMARK 465 VAL C 73 REMARK 465 TYR C 74 REMARK 465 SER C 75 REMARK 465 ASN C 76 REMARK 465 THR C 77 REMARK 465 ILE C 78 REMARK 465 GLN C 79 REMARK 465 SER C 80 REMARK 465 ILE C 81 REMARK 465 ILE C 82 REMARK 465 ALA C 83 REMARK 465 ILE C 84 REMARK 465 ILE C 85 REMARK 465 ARG C 86 REMARK 465 ALA C 87 REMARK 465 MET C 88 REMARK 465 GLY C 89 REMARK 465 ARG C 90 REMARK 465 LEU C 91 REMARK 465 LYS C 92 REMARK 465 ILE C 93 REMARK 465 ASP C 94 REMARK 465 PHE C 95 REMARK 465 GLY C 96 REMARK 465 ASP C 97 REMARK 465 SER C 98 REMARK 465 ALA C 99 REMARK 465 ARG C 100 REMARK 465 ALA C 101 REMARK 465 ASP C 102 REMARK 465 ASP C 103 REMARK 465 ALA C 104 REMARK 465 ARG C 105 REMARK 465 GLN C 106 REMARK 465 LEU C 107 REMARK 465 PHE C 108 REMARK 465 VAL C 109 REMARK 465 LEU C 110 REMARK 465 ALA C 111 REMARK 465 GLY C 112 REMARK 465 ALA C 113 REMARK 465 ALA C 114 REMARK 465 GLU C 115 REMARK 465 GLU C 116 REMARK 465 GLY C 117 REMARK 465 PHE C 118 REMARK 465 MET C 119 REMARK 465 THR C 120 REMARK 465 ALA C 121 REMARK 465 GLU C 122 REMARK 465 LEU C 123 REMARK 465 ALA C 124 REMARK 465 GLY C 125 REMARK 465 VAL C 126 REMARK 465 ILE C 127 REMARK 465 LYS C 128 REMARK 465 ARG C 129 REMARK 465 LEU C 130 REMARK 465 TRP C 131 REMARK 465 LYS C 132 REMARK 465 ASP C 133 REMARK 465 SER C 134 REMARK 465 GLY C 135 REMARK 465 VAL C 136 REMARK 465 GLN C 137 REMARK 465 ALA C 138 REMARK 465 CYS C 139 REMARK 465 PHE C 140 REMARK 465 ASN C 141 REMARK 465 ARG C 142 REMARK 465 SER C 143 REMARK 465 ARG C 144 REMARK 465 GLU C 145 REMARK 465 TYR C 146 REMARK 465 GLN C 147 REMARK 465 LEU C 148 REMARK 465 ASN C 149 REMARK 465 ASP C 150 REMARK 465 SER C 151 REMARK 465 ALA C 152 REMARK 465 ALA C 153 REMARK 465 TYR C 154 REMARK 465 TYR C 155 REMARK 465 LEU C 156 REMARK 465 ASN C 157 REMARK 465 ASP C 158 REMARK 465 LEU C 159 REMARK 465 ASP C 160 REMARK 465 ARG C 161 REMARK 465 ILE C 162 REMARK 465 ALA C 163 REMARK 465 GLN C 164 REMARK 465 PRO C 165 REMARK 465 ASN C 166 REMARK 465 TYR C 167 REMARK 465 ILE C 168 REMARK 465 PRO C 169 REMARK 465 THR C 170 REMARK 465 GLN C 171 REMARK 465 GLN C 172 REMARK 465 ASP C 173 REMARK 465 VAL C 174 REMARK 465 LEU C 175 REMARK 465 ARG C 176 REMARK 465 THR C 177 REMARK 465 ARG C 178 REMARK 465 VAL C 179 REMARK 465 SER G 8 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OG SER A 99 OE2 GLU A 121 2.12 REMARK 500 OD1 ASN A 61 OG SER A 93 2.14 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN B 313 -168.70 -123.44 REMARK 500 LEU A 91 49.87 -88.02 REMARK 500 PHE A 109 64.07 61.72 REMARK 500 MET A 195 68.62 61.66 REMARK 500 ARG A 208 -30.23 -134.13 REMARK 500 CYS A 286 -7.06 74.67 REMARK 500 LYS C 46 -3.06 67.06 REMARK 500 PHE C 215 50.72 -90.63 REMARK 500 LEU C 234 -179.00 -68.69 REMARK 500 ASN C 255 58.07 -95.31 REMARK 500 PHE C 274 46.21 -85.80 REMARK 500 LYS C 280 -66.77 -106.14 REMARK 500 GLU C 289 50.36 -91.73 REMARK 500 ASP C 328 -9.53 70.37 REMARK 500 LYS G 46 49.02 -92.27 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: EMD-36889 RELATED DB: EMDB REMARK 900 CRYO-EM STRUCTURE OF AN ACTIVE KAPOSI'S SARCOMA-ASSOCIATED REMARK 900 HERPESVIRUS-G PROTEIN-COUPLED RECEPTOR (KSHV-GPCR) IN COMPLEX WITH REMARK 900 GI PROTEIN DBREF 8K4P B 3 340 UNP P62873 GBB1_HUMAN 3 340 DBREF 8K4P A 47 340 UNP Q76SF8 Q76SF8_HHV8 47 340 DBREF 8K4P C 1 354 UNP P63096 GNAI1_HUMAN 1 354 DBREF1 8K4P G 8 62 UNP A0A6P5CFI6_BOSIN DBREF2 8K4P G A0A6P5CFI6 8 62 SEQRES 1 B 338 GLU LEU ASP GLN LEU ARG GLN GLU ALA GLU GLN LEU LYS SEQRES 2 B 338 ASN GLN ILE ARG ASP ALA ARG LYS ALA CYS ALA ASP ALA SEQRES 3 B 338 THR LEU SER GLN ILE THR ASN ASN ILE ASP PRO VAL GLY SEQRES 4 B 338 ARG ILE GLN MET ARG THR ARG ARG THR LEU ARG GLY HIS SEQRES 5 B 338 LEU ALA LYS ILE TYR ALA MET HIS TRP GLY THR ASP SER SEQRES 6 B 338 ARG LEU LEU VAL SER ALA SER GLN ASP GLY LYS LEU ILE SEQRES 7 B 338 ILE TRP ASP SER TYR THR THR ASN LYS VAL HIS ALA ILE SEQRES 8 B 338 PRO LEU ARG SER SER TRP VAL MET THR CYS ALA TYR ALA SEQRES 9 B 338 PRO SER GLY ASN TYR VAL ALA CYS GLY GLY LEU ASP ASN SEQRES 10 B 338 ILE CYS SER ILE TYR ASN LEU LYS THR ARG GLU GLY ASN SEQRES 11 B 338 VAL ARG VAL SER ARG GLU LEU ALA GLY HIS THR GLY TYR SEQRES 12 B 338 LEU SER CYS CYS ARG PHE LEU ASP ASP ASN GLN ILE VAL SEQRES 13 B 338 THR SER SER GLY ASP THR THR CYS ALA LEU TRP ASP ILE SEQRES 14 B 338 GLU THR GLY GLN GLN THR THR THR PHE THR GLY HIS THR SEQRES 15 B 338 GLY ASP VAL MET SER LEU SER LEU ALA PRO ASP THR ARG SEQRES 16 B 338 LEU PHE VAL SER GLY ALA CYS ASP ALA SER ALA LYS LEU SEQRES 17 B 338 TRP ASP VAL ARG GLU GLY MET CYS ARG GLN THR PHE THR SEQRES 18 B 338 GLY HIS GLU SER ASP ILE ASN ALA ILE CYS PHE PHE PRO SEQRES 19 B 338 ASN GLY ASN ALA PHE ALA THR GLY SER ASP ASP ALA THR SEQRES 20 B 338 CYS ARG LEU PHE ASP LEU ARG ALA ASP GLN GLU LEU MET SEQRES 21 B 338 THR TYR SER HIS ASP ASN ILE ILE CYS GLY ILE THR SER SEQRES 22 B 338 VAL SER PHE SER LYS SER GLY ARG LEU LEU LEU ALA GLY SEQRES 23 B 338 TYR ASP ASP PHE ASN CYS ASN VAL TRP ASP ALA LEU LYS SEQRES 24 B 338 ALA ASP ARG ALA GLY VAL LEU ALA GLY HIS ASP ASN ARG SEQRES 25 B 338 VAL SER CYS LEU GLY VAL THR ASP ASP GLY MET ALA VAL SEQRES 26 B 338 ALA THR GLY SER TRP ASP SER PHE LEU LYS ILE TRP ASN SEQRES 1 A 294 TYR THR TRP ASN VAL GLY ILE LEU SER LEU ILE PHE LEU SEQRES 2 A 294 ILE ASN VAL LEU GLY ASN GLY LEU VAL THR TYR ILE PHE SEQRES 3 A 294 CYS LYS HIS ARG SER ARG ALA GLY ALA ILE ASP ILE LEU SEQRES 4 A 294 LEU LEU GLY ILE CYS LEU ASN SER LEU CYS LEU SER ILE SEQRES 5 A 294 SER LEU LEU ALA GLU VAL LEU MET PHE LEU PHE PRO ASN SEQRES 6 A 294 ILE ILE SER THR GLY LEU CYS ARG LEU GLU ILE PHE PHE SEQRES 7 A 294 TYR TYR LEU TYR VAL TYR LEU ASP ILE PHE SER VAL VAL SEQRES 8 A 294 CYS VAL SER LEU VAL ARG TYR LEU LEU VAL ALA TYR SER SEQRES 9 A 294 THR ARG SER TRP PRO LYS LYS GLN SER LEU GLY TRP VAL SEQRES 10 A 294 LEU THR SER ALA ALA LEU LEU ILE ALA LEU VAL LEU SER SEQRES 11 A 294 GLY ASP ALA CYS ARG HIS ARG SER ARG VAL VAL ASP PRO SEQRES 12 A 294 VAL SER LYS GLN ALA MET CYS TYR GLU ASN ALA GLY ASN SEQRES 13 A 294 MET THR ALA ASP TRP ARG LEU HIS VAL ARG THR VAL SER SEQRES 14 A 294 VAL THR ALA GLY PHE LEU LEU PRO LEU ALA LEU LEU ILE SEQRES 15 A 294 LEU PHE TYR ALA LEU THR TRP CYS VAL VAL ARG ARG THR SEQRES 16 A 294 LYS LEU GLN ALA ARG ARG LYS VAL ARG GLY VAL ILE VAL SEQRES 17 A 294 ALA VAL VAL LEU LEU PHE PHE VAL PHE CYS PHE PRO TYR SEQRES 18 A 294 HIS VAL LEU ASN LEU LEU ASP THR LEU LEU ARG ARG ARG SEQRES 19 A 294 TRP ILE ARG ASP SER CYS TYR THR ARG GLY LEU ILE ASN SEQRES 20 A 294 VAL GLY LEU ALA VAL THR SER LEU LEU GLN ALA LEU TYR SEQRES 21 A 294 SER ALA VAL VAL PRO LEU ILE TYR SER CYS LEU GLY SER SEQRES 22 A 294 LEU PHE ARG GLN ARG MET TYR GLY LEU PHE GLN SER LEU SEQRES 23 A 294 ARG GLN SER PHE MET SER GLY ALA SEQRES 1 C 354 MET GLY CYS THR LEU SER ALA GLU ASP LYS ALA ALA VAL SEQRES 2 C 354 GLU ARG SER LYS MET ILE ASP ARG ASN LEU ARG GLU ASP SEQRES 3 C 354 GLY GLU LYS ALA ALA ARG GLU VAL LYS LEU LEU LEU LEU SEQRES 4 C 354 GLY ALA GLY GLU SER GLY LYS SER THR ILE VAL LYS GLN SEQRES 5 C 354 MET LYS ILE ILE HIS GLU ALA GLY TYR SER GLU GLU GLU SEQRES 6 C 354 CYS LYS GLN TYR LYS ALA VAL VAL TYR SER ASN THR ILE SEQRES 7 C 354 GLN SER ILE ILE ALA ILE ILE ARG ALA MET GLY ARG LEU SEQRES 8 C 354 LYS ILE ASP PHE GLY ASP SER ALA ARG ALA ASP ASP ALA SEQRES 9 C 354 ARG GLN LEU PHE VAL LEU ALA GLY ALA ALA GLU GLU GLY SEQRES 10 C 354 PHE MET THR ALA GLU LEU ALA GLY VAL ILE LYS ARG LEU SEQRES 11 C 354 TRP LYS ASP SER GLY VAL GLN ALA CYS PHE ASN ARG SER SEQRES 12 C 354 ARG GLU TYR GLN LEU ASN ASP SER ALA ALA TYR TYR LEU SEQRES 13 C 354 ASN ASP LEU ASP ARG ILE ALA GLN PRO ASN TYR ILE PRO SEQRES 14 C 354 THR GLN GLN ASP VAL LEU ARG THR ARG VAL LYS THR THR SEQRES 15 C 354 GLY ILE VAL GLU THR HIS PHE THR PHE LYS ASP LEU HIS SEQRES 16 C 354 PHE LYS MET PHE ASP VAL GLY GLY GLN ARG SER GLU ARG SEQRES 17 C 354 LYS LYS TRP ILE HIS CYS PHE GLU GLY VAL THR ALA ILE SEQRES 18 C 354 ILE PHE CYS VAL ALA LEU SER ASP TYR ASP LEU VAL LEU SEQRES 19 C 354 ALA GLU ASP GLU GLU MET ASN ARG MET HIS GLU SER MET SEQRES 20 C 354 LYS LEU PHE ASP SER ILE CYS ASN ASN LYS TRP PHE THR SEQRES 21 C 354 ASP THR SER ILE ILE LEU PHE LEU ASN LYS LYS ASP LEU SEQRES 22 C 354 PHE GLU GLU LYS ILE LYS LYS SER PRO LEU THR ILE CYS SEQRES 23 C 354 TYR PRO GLU TYR ALA GLY SER ASN THR TYR GLU GLU ALA SEQRES 24 C 354 ALA ALA TYR ILE GLN CYS GLN PHE GLU ASP LEU ASN LYS SEQRES 25 C 354 ARG LYS ASP THR LYS GLU ILE TYR THR HIS PHE THR CYS SEQRES 26 C 354 ALA THR ASP THR LYS ASN VAL GLN PHE VAL PHE ASP ALA SEQRES 27 C 354 VAL THR ASP VAL ILE ILE LYS ASN ASN LEU LYS ASP CYS SEQRES 28 C 354 GLY LEU PHE SEQRES 1 G 55 SER ILE ALA GLN ALA ARG LYS LEU VAL GLU GLN LEU LYS SEQRES 2 G 55 MET GLU ALA ASN ILE ASP ARG ILE LYS VAL SER LYS ALA SEQRES 3 G 55 ALA ALA ASP LEU MET ALA TYR CYS GLU ALA HIS ALA LYS SEQRES 4 G 55 GLU ASP PRO LEU LEU THR PRO VAL PRO ALA SER GLU ASN SEQRES 5 G 55 PRO PHE ARG HELIX 1 AA1 GLU B 3 ALA B 24 1 22 HELIX 2 AA2 THR B 29 THR B 34 1 6 HELIX 3 AA3 THR A 48 HIS A 75 1 28 HELIX 4 AA4 GLY A 80 LEU A 91 1 12 HELIX 5 AA5 ASN A 92 LEU A 105 1 14 HELIX 6 AA6 SER A 114 TYR A 149 1 36 HELIX 7 AA7 LYS A 157 ARG A 183 1 27 HELIX 8 AA8 ARG A 208 PHE A 220 1 13 HELIX 9 AA9 LEU A 221 ARG A 239 1 19 HELIX 10 AB1 ALA A 245 ARG A 279 1 35 HELIX 11 AB2 TYR A 287 GLY A 318 1 32 HELIX 12 AB3 GLY A 318 PHE A 336 1 19 HELIX 13 AB4 SER C 6 ALA C 31 1 26 HELIX 14 AB5 THR C 48 MET C 53 1 6 HELIX 15 AB6 GLU C 207 GLU C 216 5 10 HELIX 16 AB7 ASN C 241 ASN C 255 1 15 HELIX 17 AB8 ASP C 272 GLU C 275 5 4 HELIX 18 AB9 GLU C 276 SER C 281 1 6 HELIX 19 AC1 THR C 295 ASP C 309 1 15 HELIX 20 AC2 LYS C 330 CYS C 351 1 22 HELIX 21 AC3 ALA G 10 ASN G 24 1 15 HELIX 22 AC4 LYS G 29 HIS G 44 1 16 HELIX 23 AC5 ALA G 45 ASP G 48 5 4 HELIX 24 AC6 PRO G 55 ASN G 59 5 5 SHEET 1 AA1 4 ARG B 46 LEU B 51 0 SHEET 2 AA1 4 LEU B 336 ASN B 340 -1 O ASN B 340 N ARG B 46 SHEET 3 AA1 4 VAL B 327 SER B 331 -1 N THR B 329 O LYS B 337 SHEET 4 AA1 4 VAL B 315 VAL B 320 -1 N CYS B 317 O GLY B 330 SHEET 1 AA2 4 ILE B 58 TRP B 63 0 SHEET 2 AA2 4 LEU B 69 SER B 74 -1 O VAL B 71 N HIS B 62 SHEET 3 AA2 4 LYS B 78 ASP B 83 -1 O ILE B 80 N SER B 72 SHEET 4 AA2 4 LYS B 89 PRO B 94 -1 O VAL B 90 N ILE B 81 SHEET 1 AA3 4 VAL B 100 TYR B 105 0 SHEET 2 AA3 4 TYR B 111 GLY B 116 -1 O GLY B 115 N MET B 101 SHEET 3 AA3 4 CYS B 121 ASN B 125 -1 O TYR B 124 N VAL B 112 SHEET 4 AA3 4 ARG B 134 LEU B 139 -1 O ARG B 137 N ILE B 123 SHEET 1 AA4 4 LEU B 146 PHE B 151 0 SHEET 2 AA4 4 GLN B 156 SER B 161 -1 O VAL B 158 N ARG B 150 SHEET 3 AA4 4 THR B 165 ASP B 170 -1 O TRP B 169 N ILE B 157 SHEET 4 AA4 4 GLN B 175 THR B 181 -1 O THR B 177 N LEU B 168 SHEET 1 AA5 4 VAL B 187 LEU B 192 0 SHEET 2 AA5 4 LEU B 198 ALA B 203 -1 O GLY B 202 N MET B 188 SHEET 3 AA5 4 SER B 207 ASP B 212 -1 O TRP B 211 N PHE B 199 SHEET 4 AA5 4 CYS B 218 THR B 223 -1 O ARG B 219 N LEU B 210 SHEET 1 AA6 4 ILE B 229 PHE B 234 0 SHEET 2 AA6 4 ALA B 240 SER B 245 -1 O ALA B 242 N CYS B 233 SHEET 3 AA6 4 CYS B 250 ASP B 254 -1 O PHE B 253 N PHE B 241 SHEET 4 AA6 4 GLN B 259 TYR B 264 -1 O LEU B 261 N LEU B 252 SHEET 1 AA7 4 ILE B 273 PHE B 278 0 SHEET 2 AA7 4 LEU B 284 TYR B 289 -1 O LEU B 286 N SER B 277 SHEET 3 AA7 4 ASN B 293 ASP B 298 -1 O TRP B 297 N LEU B 285 SHEET 4 AA7 4 ARG B 304 ALA B 309 -1 O ALA B 305 N VAL B 296 SHEET 1 AA8 6 ILE C 184 THR C 190 0 SHEET 2 AA8 6 HIS C 195 VAL C 201 -1 O PHE C 196 N PHE C 189 SHEET 3 AA8 6 VAL C 34 GLY C 40 1 N VAL C 34 O LYS C 197 SHEET 4 AA8 6 ALA C 220 VAL C 225 1 O ILE C 222 N LEU C 39 SHEET 5 AA8 6 SER C 263 LEU C 268 1 O PHE C 267 N PHE C 223 SHEET 6 AA8 6 ILE C 319 HIS C 322 1 O TYR C 320 N LEU C 266 SSBOND 1 CYS A 118 CYS A 196 1555 1555 2.04 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000